StockPriceToday

GE Healthcare Technologies Inc (GEHC)

GEHC stock price

GE Healthcare Technologies Inc. provides medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies worldwide for healthcare providers and medical device companies.

About GE Healthcare Technologies Inc

GE Healthcare Technologies Inc. provides medical imaging, monitoring, biomanufacturing, and cell therapy technologies that enable healthcare providers to diagnose and treat patients worldwide. The company's essential role in healthcare technology has made GEHC stock price sensitive to healthcare spending trends and medical device innovation cycles.

GE Healthcare's medical imaging equipment, including MRI, CT, and ultrasound systems, helps physicians diagnose medical conditions accurately and efficiently. The company's monitoring systems provide real-time patient data that enables better clinical decision-making in hospitals and healthcare facilities.

The company's pharmaceutical diagnostics and biomanufacturing solutions support drug development and production for biotechnology and pharmaceutical companies. GE Healthcare's digital health initiatives and artificial intelligence integration enhance diagnostic capabilities while improving workflow efficiency, affecting GEHC stock price performance.

GE Healthcare's global presence and comprehensive product portfolio position it well for continued growth in the expanding healthcare technology market. The company's ability to innovate and adapt to evolving healthcare needs while maintaining its market leadership remains crucial for its long-term success and market valuation.

GEHC Stock 12 Month Chart


Latest News for GEHC

GE HealthCare stock was last at USD 64.29 on Nasdaq on October 2, 2026, up 0.48 percent from the previous close. The company is approaching a quarterly dividend of USD 0.04 per sh ...

Detailed price information for GE Healthcare Technologies (GEHC-Q) from The Globe and Mail including charting and trades.

For Q2 2026, GE HealthCare Technologies Inc. Common Stock reported EPS of $1.12, beating estimates by 7.03%, and revenue of $5.29B, -1.38% below expectations. How did the market react to GE HealthCare ...